799 related articles for article (PubMed ID: 26701265)
1. Differentiation of mammary tumors and reduction in metastasis upon Malat1 lncRNA loss.
Arun G; Diermeier S; Akerman M; Chang KC; Wilkinson JE; Hearn S; Kim Y; MacLeod AR; Krainer AR; Norton L; Brogi E; Egeblad M; Spector DL
Genes Dev; 2016 Jan; 30(1):34-51. PubMed ID: 26701265
[TBL] [Abstract][Full Text] [Related]
2. Long Non Coding RNA MALAT1 Promotes Tumor Growth and Metastasis by inducing Epithelial-Mesenchymal Transition in Oral Squamous Cell Carcinoma.
Zhou X; Liu S; Cai G; Kong L; Zhang T; Ren Y; Wu Y; Mei M; Zhang L; Wang X
Sci Rep; 2015 Nov; 5():15972. PubMed ID: 26522444
[TBL] [Abstract][Full Text] [Related]
3. Aberrant KDM5B expression promotes aggressive breast cancer through MALAT1 overexpression and downregulation of hsa-miR-448.
Bamodu OA; Huang WC; Lee WH; Wu A; Wang LS; Hsiao M; Yeh CT; Chao TY
BMC Cancer; 2016 Feb; 16():160. PubMed ID: 26917489
[TBL] [Abstract][Full Text] [Related]
4. The role of lncRNA MALAT1 in bone metastasis in patients with non-small cell lung cancer.
Liu M; Sun W; Liu Y; Dong X
Oncol Rep; 2016 Sep; 36(3):1679-85. PubMed ID: 27431200
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of MALAT1 inhibits cervical cancer cell invasion and metastasis by inhibition of epithelial-mesenchymal transition.
Sun R; Qin C; Jiang B; Fang S; Pan X; Peng L; Liu Z; Li W; Li Y; Li G
Mol Biosyst; 2016 Mar; 12(3):952-62. PubMed ID: 26798987
[TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA metastasis-associated lung adenocarcinoma transcript 1 regulates the expression of Gli2 by miR-202 to strengthen gastric cancer progression.
Zhang Y; Chen Z; Li MJ; Guo HY; Jing NC
Biomed Pharmacother; 2017 Jan; 85():264-271. PubMed ID: 27887846
[TBL] [Abstract][Full Text] [Related]
7. MALAT1 promotes angiogenesis of breast cancer.
Huang XJ; Xia Y; He GF; Zheng LL; Cai YP; Yin Y; Wu Q
Oncol Rep; 2018 Nov; 40(5):2683-2689. PubMed ID: 30226550
[TBL] [Abstract][Full Text] [Related]
8. MALAT1 predicts poor survival in osteosarcoma patients and promotes cell metastasis through associating with EZH2.
Huo Y; Li Q; Wang X; Jiao X; Zheng J; Li Z; Pan X
Oncotarget; 2017 Jul; 8(29):46993-47006. PubMed ID: 28388584
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA Malat1 promotes neurite outgrowth through activation of ERK/MAPK signalling pathway in N2a cells.
Chen L; Feng P; Zhu X; He S; Duan J; Zhou D
J Cell Mol Med; 2016 Nov; 20(11):2102-2110. PubMed ID: 27374227
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of long noncoding RNA MALAT1 induces epithelial-to-mesenchymal transition via the PI3K-AKT pathway in breast cancer.
Xu S; Sui S; Zhang J; Bai N; Shi Q; Zhang G; Gao S; You Z; Zhan C; Liu F; Pang D
Int J Clin Exp Pathol; 2015; 8(5):4881-91. PubMed ID: 26191181
[TBL] [Abstract][Full Text] [Related]
11. The noncoding RNA MALAT1 is a critical regulator of the metastasis phenotype of lung cancer cells.
Gutschner T; Hämmerle M; Eissmann M; Hsu J; Kim Y; Hung G; Revenko A; Arun G; Stentrup M; Gross M; Zörnig M; MacLeod AR; Spector DL; Diederichs S
Cancer Res; 2013 Feb; 73(3):1180-9. PubMed ID: 23243023
[TBL] [Abstract][Full Text] [Related]
12. Knockdown of long non-coding RNA MALAT1 increases the blood-tumor barrier permeability by up-regulating miR-140.
Ma J; Wang P; Yao Y; Liu Y; Li Z; Liu X; Li Z; Zhao X; Xi Z; Teng H; Liu J; Xue Y
Biochim Biophys Acta; 2016 Feb; 1859(2):324-38. PubMed ID: 26619802
[TBL] [Abstract][Full Text] [Related]
13. An antisense transcript mediates MALAT1 response in human breast cancer.
Gomes CP; Nóbrega-Pereira S; Domingues-Silva B; Rebelo K; Alves-Vale C; Marinho SP; Carvalho T; Dias S; Bernardes de Jesus B
BMC Cancer; 2019 Aug; 19(1):771. PubMed ID: 31382922
[TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA MALAT1 regulates endothelial cell function and vessel growth.
Michalik KM; You X; Manavski Y; Doddaballapur A; Zörnig M; Braun T; John D; Ponomareva Y; Chen W; Uchida S; Boon RA; Dimmeler S
Circ Res; 2014 Apr; 114(9):1389-97. PubMed ID: 24602777
[TBL] [Abstract][Full Text] [Related]
15. LncRNA MALAT1 promotes development of mantle cell lymphoma by associating with EZH2.
Wang X; Sehgal L; Jain N; Khashab T; Mathur R; Samaniego F
J Transl Med; 2016 Dec; 14(1):346. PubMed ID: 27998273
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of long noncoding RNA MALAT1 in various carcinomas: evidence from nine studies.
Xue Y; Teng YQ; Zhou JD; Rui YJ
Tumour Biol; 2016 Jan; 37(1):1211-5. PubMed ID: 26282005
[TBL] [Abstract][Full Text] [Related]
17. Reciprocal regulation of Hsa-miR-1 and long noncoding RNA MALAT1 promotes triple-negative breast cancer development.
Jin C; Yan B; Lu Q; Lin Y; Ma L
Tumour Biol; 2016 Jun; 37(6):7383-94. PubMed ID: 26676637
[TBL] [Abstract][Full Text] [Related]
18. Tumor-suppressive function of long noncoding RNA MALAT1 in glioma cells by downregulation of MMP2 and inactivation of ERK/MAPK signaling.
Han Y; Wu Z; Wu T; Huang Y; Cheng Z; Li X; Sun T; Xie X; Zhou Y; Du Z
Cell Death Dis; 2016 Mar; 7(3):e2123. PubMed ID: 26938295
[TBL] [Abstract][Full Text] [Related]
19. Malat1 as an evolutionarily conserved lncRNA, plays a positive role in regulating proliferation and maintaining undifferentiated status of early-stage hematopoietic cells.
Ma XY; Wang JH; Wang JL; Ma CX; Wang XC; Liu FS
BMC Genomics; 2015 Sep; 16(1):676. PubMed ID: 26335021
[TBL] [Abstract][Full Text] [Related]
20. The long noncoding RNA Malat1: Its physiological and pathophysiological functions.
Zhang X; Hamblin MH; Yin KJ
RNA Biol; 2017 Dec; 14(12):1705-1714. PubMed ID: 28837398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
